Gregory L. Summe
Gregory L. Summe's purchase track record
How the stock did after each of Gregory L. Summe's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/12/2026 | AVTR | $940K | -13.1% | +51.5% | +14.1% |
| 10/30/2025 | AVTR | $1.13M | -2.2% | -26.7% | +5.7% |
| 8/21/2025 | AVTR | $1.26M | -12.5% | -26.7% | +7.7% |
| 5/22/2025 | AVTR | $628K | -2.3% | -14.5% | +11.9% |
| 5/7/2025 | AVTR | $300K | -6.4% | -3.0% | +20.7% |
| 4/28/2025 | AVTR | $313K | +12.0% | +21.0% | +24.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
NXP Semiconductors rating upgraded, analysts see potential upside. NXP Semiconductors received a rating upgrade from analysts who highlight potential upside. The Guinness Sustainable Energy Fund reported improving demand indicators for the company. In the broader market, semiconductor stocks rebounded following recent weakness, aided by comments from the NY Fed President on potential policy adjustments.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Wheels Up faces sector cash‑burn concerns after recent analysis. A recent Seeking Alpha piece noted that cash burn in the aviation sector is outpacing the software revenue story for Surf Air Mobility. The observation highlights broader financial pressures that could also affect Wheels Up, which operates a similar business model. Investors may watch how the company manages its expenses in this environment.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Avantor to Report Q3 2026 Earnings on October 28. Avantor has scheduled its third-quarter 2026 earnings release for Wednesday, October 28, 2026. Recent coverage notes that the company led peer groups in research tools and consumables during the second quarter. The stock is currently trading near the lower end of its 52-week range, with analysts maintaining a wide target price spread.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
State Street Q3 Earnings Impress But Stock Remains Cautious. State Street Corporation released its third-quarter 2026 earnings, showing another strong quarter with improving margins. Despite the impressive results, the stock price has remained cautious as the market watches for fading macro tailwinds. Analysts are updating their outlooks, with one firm recently lowering its price target while maintaining its rating. The stock was also highlighted among major movers in the banking sector.
Transaction History
| GRAL | ▲ Buy | Grant | 427 | $32K | 7/15/2026 | View on chart |
| GRAL | ▲ Buy | Grant | 5,491 | $350K | 6/18/2026 | View on chart |
| NXPI | ▲ Buy | Option Exercise | 1,035 | $0 | 6/10/2026 | View on chart |
| NXPI | ▼ Sell | Tax Withholding | 513 | $153K | 6/10/2026 | View on chart |
| UP | ▲ Buy | Grant | 24,305 | $0 | 6/9/2026 | View on chart |
| AVTR | ▲ Buy | Grant | 25,270 | $0 | 5/7/2026 | View on chart |
| GRAL | ▲ Buy | Grant | 631 | $31K | 4/15/2026 | View on chart |
| AVTR | ▲ Buy | Open Market | 100,000 | $940K | 2/12/2026 | View on chart |
| GRAL | ▲ Buy | Grant | 329 | $32K | 1/15/2026 | View on chart |
| AVTR | ▲ Buy | Open Market | 100,000 | $1.1M | 10/30/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 425 | $32K | 10/15/2025 | View on chart |
| AVTR | ▲ Buy | Open Market | 100,000 | $1.3M | 8/21/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 825 | $32K | 7/15/2025 | View on chart |
| UP | ▲ Buy | Grant | 148,026 | $0 | 6/10/2025 | View on chart |
| NXPI | ▲ Buy | Option Exercise | 822 | $0 | 5/29/2025 | View on chart |
| NXPI | ▼ Sell | Tax Withholding | 407 | $80K | 5/29/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 6,082 | $250K | 5/29/2025 | View on chart |
| AVTR | ▲ Buy | Open Market | 30,000 | $375K | 5/23/2025 | View on chart |
| AVTR | ▲ Buy | Open Market | 20,000 | $253K | 5/22/2025 | View on chart |
| AVTR | ▲ Buy | Grant | 17,100 | $0 | 5/8/2025 | View on chart |
| AVTR | ▲ Buy | Open Market | 25,000 | $300K | 5/7/2025 | View on chart |
| AVTR | ▲ Buy | Open Market | 25,000 | $313K | 4/28/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 1,212 | $31K | 4/15/2025 | View on chart |
| STT | ▼ Sell | Open Market | 10,815 | $1.1M | 2/18/2025 | View on chart |
| STT | ▼ Sell | Open Market | 3,000 | $300K | 2/18/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 1,828 | $32K | 1/15/2025 | View on chart |
| GRAL | ▲ Buy | Grant | 296 | $4K | 10/30/2024 | View on chart |
| GRAL | ▲ Buy | Grant | 1,656 | $23K | 10/15/2024 | View on chart |
| UP | ▲ Buy | Grant | 87,688 | $0 | 9/11/2024 | View on chart |
| GRAL | ▲ Buy | Grant | 26,470 | $0 | 6/25/2024 | View on chart |
| NXPI | ▲ Buy | Option Exercise | 1,211 | $0 | 5/29/2024 | View on chart |
| NXPI | ▼ Sell | Tax Withholding | 600 | $168K | 5/29/2024 | View on chart |
| STT | ▲ Buy | Grant | 2,514 | $0 | 5/15/2024 | View on chart |
| AVTR | ▲ Buy | Grant | 8,477 | $0 | 5/9/2024 | View on chart |
| NXPI | ▼ Sell | Open Market | 4,695 | $1.2M | 2/28/2024 | View on chart |
| NXPI | ▼ Sell | Open Market | 3,000 | $736K | 2/28/2024 | View on chart |
| NXPI | ▲ Buy | Option Exercise | 1,482 | $0 | 5/24/2023 | View on chart |
| NXPI | ▼ Sell | Tax Withholding | 734 | $128K | 5/24/2023 | View on chart |
| STT | ▲ Buy | Grant | 2,849 | $0 | 5/17/2023 | View on chart |
| AVTR | ▲ Buy | Grant | 9,808 | $0 | 5/11/2023 | View on chart |
| NXPI | ▲ Buy | Option Exercise | 1,090 | $0 | 6/1/2022 | View on chart |
| NXPI | ▼ Sell | Tax Withholding | 540 | $102K | 6/1/2022 | View on chart |
| STT | ▲ Buy | Grant | 2,912 | $0 | 5/18/2022 | View on chart |
| AVTR | ▲ Buy | Grant | 6,693 | $0 | 5/12/2022 | View on chart |
| AVTR | ▲ Buy | Grant | 1,215 | $0 | 4/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Grail hits 12-month high after FDA panel win
Grail stock reached a 12-month high following a favorable FDA panel decision. This event has driven significant price movement, with the stock up 171% over the last six months. While some analysts view the current valuation as high, others see potential for continued growth. The company is also preparing to present new data from major clinical trials at upcoming medical conferences.
Grail hits 12-month high after FDA panel win. Grail stock reached a 12-month high following a favorable FDA panel decision. This event has driven significant price movement, with the stock up 171% over the last six months. While some analysts view the current valuation as high, others see potential for continued growth. The company is also preparing to present new data from major clinical trials at upcoming medical conferences.